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Abstract Aims/hypothesis: Evidence strongly suggests
that depression and type 2 diabetes are associated, but the
direction of the association is still unclear. Depression may
occur as a consequence of having diabetes, but may also
be a risk factor for the onset of type 2 diabetes. This study
examined the latter association by reviewing the literature
and conducting a meta-analysis of longitudinal studies on
this topic. Methods: Medline and PsycInfo were searched
for articles published up to January 2005. All studies that
examined the relationship between depression and the
onset of type 2 diabetes were included. Pooled relative
risks were calculated using fixed and random effects
models. To explore sources of heterogeneity between
studies, subgroup analyses and meta-regression analyses
were performed. Results: Nine studies met our inclusion
criteria for this meta-analysis. The pooled relative risk was
1.26 (1.13–1.39) using the fixed effects model and 1.37
(1.14–1.63) using the random effects model. Hetero-
geneity between studies could not be explained by (1)
whether studies controlled for undetected diabetes at
baseline; (2) the method of diabetes assessment at follow-
up; (3) the baseline overall risk of diabetes in the study
population; and (4) follow-up duration. Conclusions/
interpretation: Depressed adults have a 37% increased
risk of developing type 2 diabetes mellitus. The
pathophysiological mechanisms underlying this relation-
ship are still unclear and warrant further research. A
randomised controlled study is needed to test whether
effective prevention or treatment of depression can
reduce the incidence of type 2 diabetes and its health
consequences.
Keywords Depression . Diabetes . Longitudinal .
Meta-analysis . Observational studies . Risk factor
Abbreviations BRIDGE: Behavioral research in diabetes
group exchange . HPA: Hypothalamic-pituitary-
adrenocortical . PSAD: Psychosocial aspects of diabetes .
PUFA: Polyunsaturated fatty acids
Introduction
Diabetes and depression are both common conditions in
today’s society. There are currently about 200 million
people with diabetes worldwide. If nothing is done to slow
down the epidemic, the number will exceed 333 million by
the year 2025 [1]. Moreover, an estimated 121 million
people currently suffer from depression: 6% of men and
10% of women will experience a depressive episode in any
given year [2].
There is ample evidence that diabetes and depression are
associated. According to a recent meta-analysis, the
prevalence of depression is doubled in individuals with
type 2 diabetes compared with those without diabetes [3].
However, the temporal or causal relationship between
depression and type 2 diabetes remains unclear. Depression
is often regarded as a comorbid condition that results from
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the daily burden of having diabetes and/or its complica-
tions. Interestingly, there are also indications that depression
in turn is an independent risk factor for the development of
type 2 diabetes [4, 5]. This is an observation that dates back
to 1684, when the English physician Thomas Willis noted
that emotional factors such as grief or sadness could bring
on diabetes [6, 7]. About 10 years ago, Eaton and
colleagues were the first to report the results of an
epidemiological study that confirmed Willis’ hypothesis
[6]. Since then, a number of studies have investigated the
relation between depression and onset of type 2 diabetes
longitudinally, with inconsistent findings. Some report that
depression is associated with an increased risk of
developing type 2 diabetes, while other studies do not
find a significant association.
The aim of this study was to examine the relationship
between depression and the risk of onset of type 2 diabetes
by conducting a meta-analysis of longitudinal studies
published on this subject in the peer-reviewed literature.
Materials and methods
Retrieval of studies
To identify the studies of interest, two authors (F. Pouwer
and M. J. Knol) independently searched Medline (1966 to
January 2005) and PsycInfo (1872 to January 2005) using
the search terms ‘depression or depressive’ and ‘diabetes’,
limited to studies written in English and the availability of
an abstract. Titles and abstracts of the retrieved studies
were scanned to exclude studies that were clearly
irrelevant. The full texts of the remaining studies were
then read to determine whether the studies met our
inclusion criteria. Furthermore, the reference lists of
articles that indeed studied our topic of interest were
scanned to check for additional publications. Finally, in
order to minimise publication bias, all members of the
Psychosocial Aspects of Diabetes (PSAD) study group of
the European Association for the Study of Diabetes
(EASD) and the Behavioral Research In Diabetes Group
Exchange (BRIDGE) from the USA were asked by e-mail
whether they had any unpublished/rejected results of
studies investigating the relation between depression and
onset of type 2 diabetes.
Inclusion and exclusion criteria
In this meta-analysis we included all studies that long-
itudinally examined the relationship between depression
and onset of type 2 diabetes, irrespective of their study
design. Studies were excluded if the authors did not
explicitly exclude subjects with prevalent diabetes at
baseline and if there were insufficient data to estimate a
relative risk, either an odds ratio, risk ratio or hazard ratio.
When multiple publications from the same study popula-
tion were available, we included the most recent publica-
tion, regarding this study as an improvement of the older
publication, representing both studies.
Data extraction
The two authors who conducted the literature search (F.P.
and M.J.K.) also independently extracted data from the
studies, in particular regarding: (1) name of first author; (2)
publication year; (3) study design; (4) follow-up time in
years; (5) number of subjects in the analysis; (6) sex of
subjects; (7) age of subjects; (8) method of depression
assessment; (9) method of type 2 diabetes assessment; (10)
relative risk and 95% CI (the one adjusted for the largest
number of confounders); (11) adjustment for confounders;
(12) method of exclusion of diabetes patients at baseline;
and (13) overall incidence per year.
The method of depression assessment was a diagnosis of
depression assessed by a diagnostic psychiatric interview,
the assessment of depressive symptoms by a self-reported
questionnaire, or a diagnosis by a general practitioner (with
an unknown method of diagnosis). The method of
assessment of type 2 diabetes was either self-report or
screening, i.e. measuring blood glucose of all subjects. The
method of exclusion of diabetes patients at baseline was
also either self-report or screening; the latter correcting for
undetected diabetes as well.
If depressive symptoms were categorised in more than
two groups, the relative risk of the highest vs the lowest
depressive symptoms group was used. Overall incidence
per year was extracted as the crude incidence of type 2
diabetes of the whole study population, divided by follow-
up duration.
Statistical analysis
For each study, the relative risk of the most adjusted model
was used to estimate a pooled relative risk. Both the fixed
effects model and the random effects model were used. The
fixed effects model assumes that variability between
studies is exclusively due to random variation and
individual studies are simply weighted by their precision.
The random effects model assumes a different underlying
effect for each study and takes this into consideration as an
additional source of variation. A random effects meta-
analysis is more conservative than a fixed effects meta-
analysis, as it gives wider CIs around the point estimate,
and is recommended for use when heterogeneity between
studies exists [8]. In the fixed effects model the weight of
each study is equal to the inverse variance of the natural
logarithm of the relative risk. In the random effects model
an extra term is added to the variance according to the
DerSimonian and Laird method [9]. A forest plot was made
to show the relative risk and 95% CI of each study and the

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































assessment of publication bias, a funnel plot was drawn. In
this funnel plot, the relative risk for each study was plotted
on the vertical axis (logarithmic scale) against the
corresponding standard error on the horizontal axis.
Asymmetry of the funnel plot is an indicator of publication
bias. Publication bias was also assessed by means of the
Begg-adjusted rank correlation test. To check the influence
of publication bias, a pooled relative risk was calculated
when excluding the three smallest studies.
The homogeneity between the studies was assessed
visually with the forest plot and tested by means of
Cochran’s Q test, of which the null hypothesis assumes
homogeneity. In trying to explain heterogeneity between
studies we identified certain study characteristics and
assessed whether there was an association between these
characteristics and the relative risks of the included studies.
Four study characteristics were identified: (1) whether
studies controlled for undetected diabetes at baseline; (2)
the method of diabetes assessment at follow-up; (3) the
overall risk of diabetes of the particular study population;
and (4) follow-up duration. The first two characteristics are
categorical and therefore a stratified meta-analysis was
performed. The last two characteristics are continuous and
meta regression analysis was performed. In these subgroup
analyses only the random effects model was used.
Finally, the influence of adjusting for certain confoun-
ders was investigated qualitatively.
All statistical analyses were performed using STATA,
version 7.0 (Stata, College Station, TX, USA).
Results
Search results
The literature search in MEDLINE using ‘depression or
depressive’ and ‘diabetes’, limited to items with an abstract
Fig. 1 Forest plot showing the
relative risk and 95% CI of each
study and the pooled relative
risk (RR) and 95% CI using both













Fig. 2 Funnel plot showing that studies with a large standard error
(small sample size) and low relative risk (RR) are missing, which
indicates publication bias
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and written in English, resulted in 1722 articles. After
careful selection, 11 studies appeared to have studied the
relation between depression and onset of type 2 diabetes
longitudinally [10–20]. Searching the online PsycInfo
database yielded no additional studies. One of the 11
studies was excluded [17] because there was insufficient
information in the article to calculate a relative risk. Two
studies used data from the same cohort [12, 20], the
National Health and Nutrition Examination Survey
(NHANES), and the most recent publication was included
[12]. All studies excluded prevalent diabetes at baseline.
The search for unpublished work among members of the
PSAD and BRIDGE resulted in 20 responses to our e-mail
but this yielded no additional studies that met our inclusion
criteria.
The extracted data of the nine studies included in the
meta-analysis are presented in Table 1. One study reported
relative risks separately for men and women [18]. These
two relative risks were pooled using the random effects
model and this pooled relative risk (1.12) and its 95% CI
(0.82–1.53) were used in further analyses.
Meta-analysis
The forest plot shows the relative risk and 95% CI of each
study and the pooled relative risk of both the fixed effects
model and the random effects model (Fig. 1). The pooled
relative risk (95% CI) was 1.26 (1.13–1.39) using the fixed
effects model and 1.37 (1.14–1.63) using the random
effects model.
The funnel plot to detect publication bias showed some
asymmetry, as six studies lay above and three studies below
the line representing the pooled relative risk (Fig. 2).
Studies with a large standard error (small sample size) and
small relative risk are missing in the graph. This could
indicate publication bias as studies showing small (or no)
associations and large CIs are probably less often submitted
by authors and less often published by editors. The Begg-
adjusted rank correlation test for publication bias resulted
in a p value of 0.10.
The forest plot showed heterogeneity between the
studies, as the CIs of the different studies appeared to
have no or only partial overlap (Fig. 1). Cochran’s Q test
was statistically significant (Q=18.264; p=0.02), indicating
heterogeneity. Because of this heterogeneity, the pooled
relative risk resulting from the fixed effects model should
be disregarded. In further analyses only random effects
modelling was performed.
Subgroup and sensitivity analyses
The pooled relative risk (95% CI) of studies that relied on
self-reported diabetes to exclude prevalent diabetes at
baseline, and thus did not control for undetected diabetes at
baseline [10–13, 16, 18], was 1.32 (1.04–1.66) (Table 2).
The pooled relative risk (95% CI) of studies that did control
for undetected diabetes by screening all subjects for high
blood glucose [14, 15, 19] was slightly higher, namely 1.54
(1.07–2.22).
Table 2 Pooled relative risks
(using random effects meta-
analysis) stratified by exclusion
of undetected diabetes at base-
line and method of diabetes
assessment at follow-up
n Pooled relative risk (95% CI)
Overall 9 1.37 (1.14–1.63)
Exclusion of undetected diabetes at baseline
No 6 1.32 (1.04–1.66)
Yes 3 1.51 (1.11–2.06)
Method of diabetes assessment at follow-up
Self-report 4 1.32 (0.98–1.78)



























Fig. 3 Relation between natural logarithm of relative risk (log RR)
and overall incidence per year (a) and follow-up duration (b) with
regression line (solid line) and upper and lower limits of 95% CI
(dashed lines)
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The four studies [10–13] that determined type 2 diabetes
at follow-up by means of self-report had a pooled relative
risk (95% CI) of 1.32 (0.98–1.78) (Table 2). The studies
that assessed diabetes onset by measuring glucose levels
[14–16, 18, 19] instead of self-report, had a pooled relative
risk (95% CI) of 1.43 (1.12–1.81).
The overall risk of diabetes in each study, i.e. the overall
incidence per year, was plotted against the natural
logarithm of the relative risk of each study (Fig. 3a). The
regression coefficient (95% CI) was 18.6 (−35.9 to 73.1)
but not significantly different from zero, which means there
is no relation between overall risk of diabetes and relative
risk. Also, no relation was found between follow-up
duration and relative risk, as can be seen in the plot
(Fig. 3b). The regression coefficient (95% CI) was −0.0018
(−0.045 to 0.042).
A sensitivity analysis was performed to determine
whether excluding the Dutch study [10] influenced the
pooled relative risk, as this particular study used routine
care data and doctor’s diagnosis to measure depression
instead of screening by means of a diagnostic interview or
questionnaire. When this study [10] was excluded the
pooled relative risk (95% CI) was 1.44 (1.21–1.71), which
is slightly larger than the pooled relative risk if that study
was included in the analysis. When the three studies with
the smallest sample size [13, 16, 19] were excluded the
pooled relative risk (95% CI) was 1.24 (1.06–1.46). To
check the influence of our decision to include the most
recent publication when multiple publications from the
same study population were available, we excluded the
study of Carnethon et al. [12] and included the study of
Saydah et al. [20]. This resulted in a pooled relative risk
(95% CI) of 1.26 (1.08–1.47).
Influence of adjusting for confounders
Table 3 presents an overview of the unadjusted and
adjusted relative risks (95% CI) which were reported by
each study, with a detailed description of the different sets
of confounders that were used. Unfortunately, as the
studies adjusted for many different sets of confounders, it is
Table 3 Overview of unadjusted and adjusted relative risks reported in each study, with a description of all confounders that were used
Study Relative risk (95% CI) Adjustment for confoundersc
Eaton et al. 1996 [13] 1.58 (0.71–3.51) –
2.05 (0.85–4.94) 1, 2, 3
2.23 (0.90–5.55) 1, 2, 3, 8
Kawakami et al. 1999 [16] 2.04 (0.93–4.45) –
2.32 (1.06–5.08) 1
2.31 (1.03–5.20) 1, 5, 6, 7, 8, 12, 13, 14, 24, 29
Carnethon et al. 2003 [12] 2.52 (1.73–3.67) 1, 2, 3
1.86 (1.27–2.71) 1, 2, 3, 8, 12, 13, 14
Arroyo et al. 2004 [11] 1.47 (1.20–1.79) –
1.55 (1.27–1.90) 1
1.36 (1.11–1.67) 1, 8
1.22 (1.00–1.50) 1, 8, 12, 13, 14, 16, 23, 29
Golden et al. 2004 [15] 1.63 (1.31–2.02) 1, 2, 3, 5
1.38 (1.10–1.73) 1, 2, 3, 5, 8, 10, 15, 17, 18, 19, 20
1.51 (1.21–1.89) 1, 2, 3, 5, 12, 13, 21
1.28 (1.02–1.60) 1, 2, 3, 5, 8, 10, 12, 13, 21
1.31 (1.04–1.64) 1, 2, 3, 5, 8, 10, 12, 13, 15, 17, 18, 19, 20, 21
Kumari et al. 2004 [18] 1.17 (0.8–1.7)a 1.08 (0.6–1.9)b 1, 3, 4, 22, 28
1.17 (0.8–1.7)a 1.03 (0.6–1.8)b 1, 3, 4, 8, 11, 12, 13, 15, 22, 25, 28, 29
Palinkas et al. 2004 [19] 2.50 (1.29–4.87) 1, 2, 8, 12
van den Akker et al. 2004 [10] 1.41 (1.15–1.73) –
1.04 (0.84–1.28) 1, 2, 4
0.98 (0.79–1.21) 1, 2, 4, 8
Everson-Rose et al. 2004 [14] 1.66 (1.05–2.61) 1, 3, 5, 26, 27
1.46 (0.90–2.36) 1, 3, 5, 9, 12, 26, 27
aSubgroup analysis of male subjects
bSubgroup analysis of female subjects
c1, age; 2, sex; 3, race; 4, socio-economic status; 5, education; 6, occupation; 7, shift work; 8, body mass index; 9, waist circumference;
10, waist-to-hip ratio; 11, height; 12, physical activity; 13, smoking; 14, alcohol consumption; 15, systolic blood pressure; 16, history of
hypertension; 17, HDL cholesterol; 18, triglycerides; 19, fasting insulin; 20, fasting glucose; 21, caloric intake; 22, ECG abnormalities;
23, menopausal status; 24, chronic medical conditions; 25, life events; 26, use of medication for depression; 27, study site; 28, length of
follow-up; 29, family history of diabetes
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impossible to quantify the exact influence of adjusting for
certain confounders. Qualitatively, no association was seen
between adjustment for certain confounders and the
magnitudes of the relative risks, as some relative risks
decreased after adjusting for certain confounders and
others increased.
Discussion
To our knowledge, this study represents the first applica-
tion of meta-analysis of literature regarding depression as a
risk factor for the onset of type 2 diabetes mellitus.
Results of this meta-analysis of nine longitudinal studies
suggest that adults with depression or high-depressive
symptoms have a 37% increased risk of developing type 2
diabetes compared with those who are not depressed or
have low-depressive symptoms. Heterogeneity between
studies regarding relative risks could not be explained by:
(1) whether studies controlled for undetected diabetes at
baseline; (2) the method of diabetes assessment at follow-
up; (3) the baseline overall risk of diabetes in the study
population; or (4) follow-up duration. Also, adjustment for
several confounders did not explain differences in effect
sizes between studies.
Before drawing a conclusion on the findings of this
meta-analysis, we will discuss several biases which may
have confounded our results. First, reversed causality could
be an issue. In reversed causality, presymptomatic persons
with diabetes develop depression. These subjects are more
likely to develop symptomatic diabetes and this will
overestimate the effect size. However, we believe that this
hypothesis is less probable, as we have found that studies
that exclude cases with undetected diabetes at baseline
showed a pooled relative risk similar to the overall pooled
relative risk. Second, ascertainment or diagnostic bias
could play a role in explaining the results of the present
meta-analysis. Subjects with depression tend to visit their
doctor more often and may thus be more likely to be
recognised as having diabetes [21]. This bias could have
occurred particularly in studies that relied on self-reported
diabetes at follow-up. However, the pooled relative risk of
studies that assessed diabetes by measuring glucose levels
(as opposed to self-report or doctor’s diagnosis) appeared
to be similar to the overall pooled relative risk. These
findings do not support the notion that ascertainment bias
explains the results of our study. Third, although all studies
adjusted for multiple potential confounders, residual
confounding may have influenced our findings. Given
the fact that most of the studies adjusted for a considerable
number of confounders (median 7, range 4–14), we
consider this as less likely. In contrast, overcorrection
may have occurred. It may be true that some studies
adjusted for intermediate rather than confounding factors,
resulting in underestimation of the pooled relative risk. A
fourth potential bias of the present meta-analysis is
publication bias, which is a threat to the validity of every
systematic review. We tried to minimise publication bias by
asking members of relevant study groups whether they had
any unpublished/rejected results of studies investigating
the relation between depression and the onset of type 2
diabetes. Still, the funnel plot did show some asymmetry,
as studies with a small sample size and low relative risk
were missing, which indicates publication bias. However,
even after excluding the three smallest studies [13, 16, 19]
a significant, pooled relative risk was found. In sum,
reversed causality, ascertainment bias, confounding factors
and publication bias do not seem to explain the relationship
found in this meta-analysis.
Another potential problem in this meta-analysis is that
each study used a different method to assess depression.
These different methods can be categorised into four
hierarchical groups. First, only one study used a diagnostic
interview schedule [13], which is the gold standard for the
diagnosis of major depression. Second, four studies used
validated depression severity scales, the Zung Depression
Scale, the General Health Questionnaire, the Beck Depres-
sion Inventory and the Center for Epidemiological Studies
Depression Scale [14, 16, 18, 19]. In these studies,
validated cutoff scores were used to define levels of
depressive affect. The sensitivity and specificity of these
measures proved to be acceptable [22]. As a third measure
of depression, three studies used semi-depression severity
scales: the General Well-Being Depression Scale, the
Mental Health Index of the SF-36 and the Vital Exhaustion
Scale [11, 12, 15]. These measures were not designed to
measure depression severity but are commonly used as a
proximal measure of negative affect. The relative risks
found in the studies that used these semi-depression scales
were similar to the relative risks of the studies that used the
more sophisticated scales, and showed the same direction
of effect. Finally, one study used the general practitioner’s
diagnosis of depression [10]. It has been reported that
depressive symptoms are not recognised in about half of
attending patients with depressive disorders in UK general
practice [23] and this under-recognition of depression
would result in underestimation of the effect size between
depression and onset of diabetes. Therefore, we performed
a sensitivity analysis excluding this study, which resulted in
a slightly higher pooled relative risk: 1.44 (1.21–1.71).
A second issue in the method of assessment of de-
pression is that two studies made three categories of
depression level [12, 16] and one study divided the
depression scores into quartiles [15]. This might have
influenced our results, as we used the relative risk of the
highest vs the lowest group of depressive symptoms. It is
seen, in these three studies, that the relative risk of the
highest vs the lowest group is larger than the relative risks
for the other categories. An additional stratified analysis
also showed that the pooled relative risk for these three
studies is somewhat higher (1.59 [1.16–2.17]) than the
pooled relative risk of the other studies (1.26 [1.02–1.56]).
However, we still believe that the relative risk of the lowest
vs the highest category of depression represents best the
difference between ‘no/yes’ depression.
In the literature, several hypotheses have been described
regarding the pathophysiological mechanisms that could
explain the increased risk of type 2 diabetes in depressed
843
subjects. First, the hypothesis of increased activity of the
hypothalamic-pituitary-adrenocortical (HPA) axis and
sympathetic nervous system will be discussed. Depression
is associated with increased activity of the HPA axis and
the sympathetic nervous system [24], resulting in increased
cortisol release and increased release of the catecholamines
epinephrine and norepinephrine. Cortisol is a stress
hormone, which stimulates glucose production, increases
lipolysis and circulating free fatty acids, decreases insulin
secretion from beta cells and decreases sensitivity to insulin
[24–27]. It is postulated that a chronically high cortisol
level, which is a feature of about 50% of depressed
patients, results in obesity, insulin resistance and type 2
diabetes [24, 28, 29]. Some studies found evidence for this
hypothesis [27, 28]. Epinephrine generates responses in
glucose and fat metabolism similar to those of cortisol [26],
also possibly resulting in insulin resistance and type 2
diabetes.
The credibility of this hypothesis is further strengthened
by findings on other medical problems that are accom-
panied by hypercortisolaemia. For example, Cushing’s
syndrome, sleeping disorders, work stress and schizophre-
nia [30–33] appeared to be associated with an increased
level of cortisol and also with an increased risk of type 2
diabetes and insulin resistance, although studies on sleep
disorders showed inconsistent results regarding risk of
diabetes [33–37].
A second hypothesis is that dysregulation of the immune
system plays a role in the relationship between depression
and increased risk of type 2 diabetes. Both depression and
type 2 diabetes are found to be associated with increased C-
reactive protein, TNF-α and proinflammatory cytokines,
including IL-6 [38–42]. A contradiction between this
hypothesis and the first hypothesis is that cortisol inhibits
inflammation and the immune response, whereas depres-
sion is associated with both elevated cortisol and increased
inflammatory markers. A recent finding possibly explains
this contradiction by showing that melancholic depressed
patients had increased HPA axis activity and no signs of
inflammation, whereas non-melancholic depressed patients
did show signs of inflammation and normal HPA axis
activity [43].
Finally, a low intake or impaired metabolism of ω-3
polyunsaturated fatty acids (PUFA) could contribute to
both depression and type 2 diabetes.ω-3 PUFA have direct
and indirect actions on cerebral function and depletion of
these fatty acids is clearly associated with psychiatric
illness, including depression [44, 45]. In addition, there is
evidence that a low intake of ω-3 PUFA is associated with
an increased risk of type 2 diabetes, but these results were
concluded to be less convincing [44].
It is known that the most important risk factor for type 2
diabetes is obesity [46, 47], and that physical inactivity
further increases the risk, independently of obesity [48]. In
view of the findings in our meta-analysis, depressive affect
could be regarded as an additional risk factor for type 2
diabetes, comparable in size to smoking and physical
activity [47, 49]. Clinicians should be made aware of the
fact that depressive affect might be an additional risk factor
for type 2 diabetes as this makes adequate detection and
treatment of depression even more important than it already
is. Assessing fasting glucose and advising exercise in
depressed patients might also prevent type 2 diabetes.
In conclusion, this meta-analysis suggests that depres-
sion is a risk factor for the onset of type 2 diabetes mellitus,
comparable in size to smoking and physical activity.
However, further well-designed research with adequate
control for confounding factors is needed to establish the
exact size of the relationship. The influence of the duration
of depression or the change in depression over time on the
risk of type 2 diabetes should be studied especially.
Furthermore, research is warranted to elucidate the
pathophysiological mechanisms underlying the associa-
tion. With the expectation of more than 100 million new
cases of type 2 diabetes in the coming two decades,
prevention becomes more important every day. Whether
the prevention of depression or the treatment of depressed
people can truly prevent or delay the onset of type 2
diabetes mellitus remains to be tested in long-term
intervention studies.
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